In a recent population-based cohort study conducted in Sweden, the risk of squamous cell cancer (SCC) and basal cell cancer (BCC) was evaluated in patients with RA naïve to biologic drugs, in patients starting TNF inhibitors treatment, and in the general population. Here, TNF is linked to rheumatoid arthritis.